Sky-high drug prices are a huge issue for many Americans who can’t pay for necessary medications, and 78% feel the federal government should be able to negotiate better prices.

Digital health companies continued raking in venture capital during the first three quarters of 2019, according to a new report from Mercom Capital Group, but the number of deals and the value is about 10% lower year over year.

The majority of Americans don’t believe President Trump has a healthcare plan to replace the Affordable Care Act. While Trump has touted that he will release a healthcare plan and that his administration already had an outline for a plan back in June, he has yet to release anything.

The Trump administration’s efforts to change the Medicaid program by allowing states to implement work requirements could be under threat as they are challenged in court and threatened by a new report that shows the steep cost of putting the changes into place.

A handful of states are contemplating leaving the federal healthcare marketplace in favor of their own state-based marketplace. 

Medicare may be shelling out an extra $1.2 billion in overpayments for graduate medical education (GME), which trains medical residents, according to a study published in JAMA Internal Medicine.

Johnson & Johnson was hit with an $8 billion judgment and ordered to pay a Maryland man after the company failed to sufficiently warn users that its antipsychotic drug Risperdal could cause breast growth in men.

The healthcare uninsured rate in the U.S. is rising, but not all cities are seeing the same decline. WalletHub took a look at 548 U.S. cities to compare insurance coverage rates, ranking the highest and lowest cities by uninsured rate.